Drug Interactions between Azithromycin Dose Pack and lisinopril
This report displays the potential drug interactions for the following 2 drugs:
- Azithromycin Dose Pack (azithromycin)
- lisinopril
Interactions between your drugs
No interactions were found between Azithromycin Dose Pack and lisinopril. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
Azithromycin Dose Pack
A total of 326 drugs are known to interact with Azithromycin Dose Pack.
- Azithromycin dose pack is in the drug class macrolides.
-
Azithromycin dose pack is used to treat the following conditions:
- Babesiosis
- Bacterial Endocarditis Prevention
- Bacterial Infection
- Bartonellosis
- Bronchitis
- Cervicitis
- Chancroid
- Chlamydia Infection
- COPD, Acute
- Cystic Fibrosis
- Gonococcal Infection, Uncomplicated
- Granuloma Inguinale
- Legionella Pneumonia
- Lyme Disease, Erythema Chronicum Migrans
- Mycobacterium avium-intracellulare, Prophylaxis
- Mycobacterium avium-intracellulare, Treatment
- Mycoplasma Pneumonia
- Nongonococcal Urethritis
- Otitis Media
- Pelvic Inflammatory Disease
- Pertussis
- Pertussis Prophylaxis
- Pharyngitis
- Pneumonia
- Sinusitis
- Skin and Structure Infection
- Skin or Soft Tissue Infection
- STD Prophylaxis
- Tonsillitis/Pharyngitis
- Toxoplasmosis
- Typhoid Fever
- Upper Respiratory Tract Infection
lisinopril
A total of 366 drugs are known to interact with lisinopril.
- Lisinopril is in the drug class Angiotensin Converting Enzyme Inhibitors.
- Lisinopril is used to treat the following conditions:
Drug and food interactions
lisinopril food
Applies to: lisinopril
It is recommended that if you are taking lisinopril you should be advised to avoid moderately high or high potassium dietary intake. This can cause high levels of potassium in your blood. Do not use salt substitutes or potassium supplements while taking lisinopril, unless your doctor has told you to.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See Also
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.